{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:01:06Z","timestamp":1787860866964,"version":"build-2784847793"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013995","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}}],"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","award":["Research Chair on Pandemic Preparedness"],"award-info":[{"award-number":["Research Chair on Pandemic Preparedness"]}],"id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Following decades of progress, recent years have seen a resurgence of cholera. This has led to unprecedented demand for vaccines from the global emergency stockpile of oral cholera vaccines (OCVs), for outbreak and humanitarian use. As a consequence of chronic supply shortages, preventive vaccination has been suspended since 2022. Although strategic demand scenarios have been published for OCV, models that integrate OCV supply and demand across long time horizons are lacking. Therefore, a quantitative system dynamics model is presented to simulate OCV market dynamics between 2013\u20132035. The model considers the evolving OCV supply landscape as well as the impact of preventive efforts. Building on stakeholder-driven scenario design, simulations help identify leverage points to improve OCV market health and assess the individual and combined effect of interventions on accelerating cholera control. Specifically, country adoption of preventive vaccination programs and complementary investments in water and sanitation infrastructure are critical to reduce the risk of cholera. Although more resource-intensive, re-vaccination of at-risk populations helps sustain outbreak prevention. It also offers potential benefits such as increasing long-term demand predictability and the overall market size. These serve as important incentives to maintain supplier diversity, thus improving market health. However, since many cholera endemic countries rely on donor support to access OCV, budget constraints associated with reduced development aid can jeopardize programmatic ambitions. Interventions such as the use of rapid diagnostic tests and price competition of procurement can help meet country needs. Finally, market dynamics are influenced by the policies around when to resume preventive OCV use in endemic countries and 2-dose reactive vaccination. Specifically, inventory policies based on the current available stock level versus incoming stock in transit are compared. Aligning OCV supply with demand, both in time and quantity, will be critical to address immediate needs and support broader multi-sectoral activities towards cholera elimination.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013995","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:40:56Z","timestamp":1772131256000},"page":"e0013995","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Strategies for achieving a healthy oral cholera vaccine market: Model-enabled scenario exploration of supply and demand dynamics"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5238","authenticated-orcid":true,"given":"Donovan","family":"Guttieres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Van Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Vandaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Decouttere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"1","key":"pntd.0013995.ref001","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12889-020-08521-y","article-title":"What are the drivers of recurrent cholera transmission in Nigeria? Evidence from a scoping review","volume":"20","author":"KO Elimian","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"pntd.0013995.ref002","article-title":"Exploring the burden of cholera in the WHO African region: patterns and trends from 2000 to 2023 cholera outbreak data","volume":"10","author":"EL Koua","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"8","key":"pntd.0013995.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011597","article-title":"Drivers of the dynamics of the spread of cholera in the Democratic Republic of the Congo, 2000-2018: An eco-epidemiological study","volume":"17","author":"HC Kayembe","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013995.ref004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016168","article-title":"An assessment of the progress made in the implementation of the regional framework for cholera prevention and control in the WHO African region","volume":"10","author":"F Kapaya","year":"2025","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pntd.0013995.ref005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12936-021-03998-3","article-title":"Supporting countries to achieve their malaria elimination goals: the WHO E-2020 initiative","volume":"20","author":"KA Lindblade","year":"2021","journal-title":"Malar J"},{"key":"pntd.0013995.ref006","article-title":"Cholera surveillance and estimation of burden of cholera","author":"D Ganesan","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0013995.ref007","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"M Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013995.ref008","doi-asserted-by":"crossref","first-page":"1607990","DOI":"10.3389\/ijph.2024.1607990","article-title":"Unmasking the Neglected Cholera Outbreaks in Sub-Saharan Africa","volume":"69","author":"B Siamalube","year":"2025","journal-title":"Int J Public Health"},{"issue":"30","key":"pntd.0013995.ref009","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.vaccine.2018.05.120","article-title":"The health economics of cholera: A systematic review","volume":"36","author":"A Hsiao","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0013995.ref010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","article-title":"Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis","volume":"12","author":"DOMI Cholera Economics Study Group","year":"2009","journal-title":"Value Health"},{"issue":"4","key":"pntd.0013995.ref011","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/ije\/dyz060","article-title":"Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial","volume":"48","author":"M Ali","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"34","key":"pntd.0013995.ref012","first-page":"477","article-title":"Cholera vaccines: WHO position paper \u2013 August 2017","volume":"92","author":"WHO","year":"2017","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0013995.ref013","unstructured":"GTFCC. Ending cholera: a global roadmap to 2030. 2017. https:\/\/www.gtfcc.org\/wp-content\/uploads\/2020\/09\/ending-cholera-a-global-roadmap-to-2030.pdf"},{"key":"pntd.0013995.ref014","unstructured":"Russell A, Luquero F, Bullock O. Gavi support for OCV programme: GTFCC OCV working group annual meeting. 2022."},{"key":"pntd.0013995.ref015","unstructured":"GAVI. Gavi Alliance Market Shaping Roadmap for Oral Cholera Vaccines. 2023."},{"issue":"4","key":"pntd.0013995.ref016","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(16)00037-1","article-title":"A second affordable oral cholera vaccine: implications for the global vaccine stockpile","volume":"4","author":"SN Desai","year":"2016","journal-title":"Lancet Glob Health"},{"key":"pntd.0013995.ref017","unstructured":"UNICEF. Gavi and UNICEF welcome approval of new oral cholera vaccine. https:\/\/www.unicef.org\/press-releases\/gavi-and-unicef-welcome-approval-new-oral-cholera-vaccine 2024. 2025 April 2."},{"key":"pntd.0013995.ref018","article-title":"How did the world run so low on cholera vaccine?","author":"G Emanuel","year":"2024","journal-title":"NPR"},{"issue":"1","key":"pntd.0013995.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003599","article-title":"The 30-year evolution of oral cholera vaccines: A case study of a collaborative network alternative innovation model","volume":"5","author":"K Large","year":"2025","journal-title":"PLOS Glob Public Health"},{"issue":"10430","key":"pntd.0013995.ref020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(24)00467-7","article-title":"The great cholera vaccine shortage","volume":"403","author":"T Burki","year":"2024","journal-title":"Lancet"},{"key":"pntd.0013995.ref021","unstructured":"WHO. Shortage of cholera vaccines leads to temporary suspension of two-dose strategy, as cases rise worldwide. https:\/\/www.who.int\/news\/item\/19-10-2022-shortage-of-cholera-vaccines-leads-to-temporary-suspension-of-two-dose-strategy--as-cases-rise-worldwide 2022. 2024 June 6."},{"issue":"9","key":"pntd.0013995.ref022","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"MF Franke","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0013995.ref023","doi-asserted-by":"crossref","first-page":"109210","DOI":"10.1016\/j.mbs.2024.109210","article-title":"Modelling techniques in cholera epidemiology: A systematic and critical review","volume":"373","author":"LM Anteneh","year":"2024","journal-title":"Math Biosci"},{"issue":"8","key":"pntd.0013995.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001867","article-title":"The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study","volume":"12","author":"AS Azman","year":"2015","journal-title":"PLoS Med"},{"issue":"4","key":"pntd.0013995.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010358","article-title":"Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study","volume":"16","author":"T Leung","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0013995.ref026","article-title":"Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects","volume":"12","author":"CM Peak","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0013995.ref027","article-title":"The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis","volume":"12","author":"AI Khan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0013995.ref028","article-title":"The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study","volume":"16","author":"EC Lee","year":"2019","journal-title":"PLoS Med"},{"issue":"18","key":"pntd.0013995.ref029","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.vaccine.2016.03.004","article-title":"Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study","volume":"34","author":"J-H Kim","year":"2016","journal-title":"Vaccine"},{"issue":"10133","key":"pntd.0013995.ref030","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(17)33050-7","article-title":"Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales","volume":"391","author":"J Lessler","year":"2018","journal-title":"Lancet"},{"key":"pntd.0013995.ref031","volume-title":"Business dynamics: Systems thinking and modeling for a complex world","author":"J Sterman","year":"2000","edition":"6"},{"key":"pntd.0013995.ref032","doi-asserted-by":"crossref","DOI":"10.1590\/0103-6513.20190062","article-title":"System dynamics for social good","volume":"29","author":"P Gon\u00e7alves","year":"2019","journal-title":"Prod"},{"key":"pntd.0013995.ref033","unstructured":"WHO. Implementing the Immunization Agenda 2030. 2021."},{"issue":"49","key":"pntd.0013995.ref034","first-page":"719","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: Conclusions and Recommendations","volume":"2024","author":"WHO","year":"2024","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0013995.ref035","volume-title":"Small System Dynamics Models for Big Issues: Triple Jump towards Real-World Dynamic Complexity","author":"E Pruyt","year":"2013"},{"key":"pntd.0013995.ref036","unstructured":"WHO. List of prequalified vaccines. https:\/\/extranet.who.int\/prequal\/vaccines\/list-prequalified-vaccines 2025. 2025 April 2."},{"key":"pntd.0013995.ref037","unstructured":"WHO. ICG: Cholera. https:\/\/www.who.int\/groups\/icg\/cholera 2025. 2025 April 2."},{"key":"pntd.0013995.ref038","unstructured":"Global Task Force on Cholera Control. https:\/\/www.gtfcc.org\/ 2025. 2025 April 2."},{"key":"pntd.0013995.ref039","unstructured":"GTFCC. GTFCC OCV Dashboard. https:\/\/apps.epicentre-msf.org\/public\/app\/gtfcc 2025 April 2."},{"key":"pntd.0013995.ref040","unstructured":"UNICEF. Oral cholera vaccine (OCV) price data. https:\/\/www.unicef.org\/supply\/documents\/oral-cholera-vaccine-ocv-price-data 2025. 2025 April 2."},{"key":"pntd.0013995.ref041","unstructured":"Chen C, Noble I, Hellmann J, Coffee J, Murillo M, Chawla N. University of Notre Dame Global Adaptation Initiative: Country Index Technical Report. 2024."},{"key":"pntd.0013995.ref042","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/978-1-4419-7701-4_41","article-title":"System Dynamics in the Evolution of the Systems Approach","author":"M Schwaninger","year":"2009","journal-title":"Complex Systems in Finance and Econometrics. Springer New York"},{"key":"pntd.0013995.ref043","unstructured":"Barlas Y. In: 1994."},{"key":"pntd.0013995.ref044","unstructured":"Forrester J, Senge P. Tests for building confidence in system dynamics models. 1979."},{"key":"pntd.0013995.ref045","unstructured":"Park R. EuBiologics\u2019 update: WHO GTFCC OCV WG Meeting. 2024."},{"issue":"10","key":"pntd.0013995.ref046","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015367","article-title":"Water, sanitation and hygiene (WASH): the evolution of a global health and development sector","volume":"9","author":"S de Wit","year":"2024","journal-title":"BMJ Glob Health"},{"key":"pntd.0013995.ref047","unstructured":"Keller J, Landers C, Martinez N, Eldridge R. 2024\u20132025 replenishment traffic jam redux: Are donors getting into gear?. 2025."},{"key":"pntd.0013995.ref048","article-title":"Vaccine alliance battles for funds as donors face financial pressures","author":"M Peel","year":"2024"},{"key":"pntd.0013995.ref049","unstructured":"Sinha A. Supporting cholera diagnostics. 2023."},{"key":"pntd.0013995.ref050","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae194","article-title":"Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023","volume":"79","author":"M Edosa","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"10133","key":"pntd.0013995.ref051","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(17)33050-7","article-title":"Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales","volume":"391","author":"J Lessler","year":"2018","journal-title":"Lancet"},{"key":"pntd.0013995.ref052","doi-asserted-by":"crossref","first-page":"103044","DOI":"10.1016\/j.eclinm.2024.103044","article-title":"Time to invest in cholera","volume":"80","author":"RC Stout","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"7","key":"pntd.0013995.ref053","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2666-5247(24)00133-2","article-title":"New measures to tackle the global cholera surge","volume":"5","author":"P Venkatesan","year":"2024","journal-title":"Lancet Microbe"},{"issue":"32","key":"pntd.0013995.ref054","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1016\/j.vaccine.2021.06.034","article-title":"Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia","volume":"39","author":"J Mwaba","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"pntd.0013995.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"S Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013995.ref056","unstructured":"GTFCC. Cholera roadmap: research agenda. 2021."},{"issue":"10422","key":"pntd.0013995.ref057","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(23)02244-4","article-title":"Moving cholera vaccines ahead of the epidemic curve","volume":"403","author":"ZA Memish","year":"2024","journal-title":"Lancet"},{"key":"pntd.0013995.ref058","unstructured":"UNICEF. Emergency stockpile availability - oral cholera vaccine. 2025. Available from: https:\/\/www.unicef.org\/supply\/documents\/emergency-stockpile-availability-oral-cholera-vaccine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013995","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:45:36Z","timestamp":1772649936000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013995"}},"subtitle":[],"editor":[{"given":"Jeffrey H","family":"Withey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013995","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}